These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19113791)
1. Where does high-quality research in economic evaluation come from? Zhang JX Pharmacotherapy; 2009 Jan; 29(1):1-2. PubMed ID: 19113791 [No Abstract] [Full Text] [Related]
2. Using pharmaceutical cost analyses for decision making. U'Ren NA Hosp Cost Manag Account; 1997 Nov; 9(8):1-7. PubMed ID: 10178832 [No Abstract] [Full Text] [Related]
3. A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents. Hakim Z; Pierson JF; Pathak DS Pharm Pract Manag Q; 1996 Apr; 16(1):79-97. PubMed ID: 10157744 [No Abstract] [Full Text] [Related]
4. Evaluation and justification of clinical pharmacy services. Anderson SV; Schumock GT Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):539-45. PubMed ID: 19941431 [TBL] [Abstract][Full Text] [Related]
5. Transparent and reproducible reports of economic evaluations of clinical pharmacy services: a goal for the future? Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT Am J Health Syst Pharm; 2009 Mar; 66(5):442-3; author reply 443-4. PubMed ID: 19233988 [No Abstract] [Full Text] [Related]
6. Incorporating pharmacoeconomic principles into hospital pharmacy practice. Gouveia WA; Bungay KM Top Hosp Pharm Manage; 1994 Jan; 13(4):31-7. PubMed ID: 10130681 [TBL] [Abstract][Full Text] [Related]
10. Getting the most out of pharmacoeconomics. Arikian SR Healthc Exec; 1993; 8(5):45. PubMed ID: 10128403 [No Abstract] [Full Text] [Related]
11. Cost benefit and cost effectiveness analysis: a bibliography for pharmacists. Lunik MC; Segal R Hosp Pharm; 1986 Nov; 21(11):1072-5. PubMed ID: 10311748 [TBL] [Abstract][Full Text] [Related]
12. Reform calls for new relationships. Black RC Healthc Exec; 1993; 8(3):25. PubMed ID: 10125603 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the quality of published pharmacoeconomic evaluations. Sanchez LA Hosp Pharm; 1995 Feb; 30(2):146-8, 151-2. PubMed ID: 10140528 [No Abstract] [Full Text] [Related]
14. [Hospital essential drugs in Africa. An example of pharmacoeconomic research]. Meillon C; Stum N; Cuisinier-Raynal JC Dakar Med; 1996; Spec No():19-20. PubMed ID: 14520980 [No Abstract] [Full Text] [Related]
15. Economic aspects of pharmacokinetic services. Destache CJ Pharmacoeconomics; 1993 Jun; 3(6):433-6. PubMed ID: 10146877 [No Abstract] [Full Text] [Related]
16. Statistical comments. Kikushi T Value Health; 2008; 11(2):345; discussion 346. PubMed ID: 18380647 [No Abstract] [Full Text] [Related]
17. Clinical and economic benefits of a clinical pharmacokinetic service: 1987 versus 1992 data. Destache CJ Med Interface; 1994 Nov; 7(11):84-6, 89-90. PubMed ID: 10138706 [No Abstract] [Full Text] [Related]